• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    7.65 Down 0.17(2.17%) 4:00PM EST
    |After Hours : 7.65 0.00 (0.00%) 4:00PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.82
    Open:7.90
    Bid:7.62 x 300
    Ask:7.65 x 700
    1y Target Est:10.19
    Beta:1.41
    Next Earnings Date:N/A
    Day's Range:7.61 - 8.06
    52wk Range:3.34 - 8.06
    Volume:5,811,289
    Avg Vol (3m):4,570,520
    Market Cap:1.82B
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 2.17%1.82B
    MRKDown 1.77%175.19B
    NVSDown 1.84%234.88B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):57.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.31
    Quarterly EPS Est (Dec-14) :-0.08
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback